Table 2 Bassline echocardiographic findings of the patients among the two cardiotoxicity and non-cardiotoxicity groups.
Total population (n = 100) | Non-cardiotoxicity (n = 59) | Cardiotoxicity (n = 41) | P value | |
|---|---|---|---|---|
RVID, cm | 3.30 ± 3.06 | 3.56 ± 4 | 2.93 ± 0.28 | 0.37 |
LVIDd, cm | 4.66 ± 0.62 | 4.78 ± 0.73 | 4.5 ± 0.42 | 0.03* |
LVIDs, cm | 3.84 ± 5.08 | 4.5 ± 6.8 | 3.02 ± 0.54 | 0.23 |
IVSD, cm | 0.92 ± 0.99 | 1.03 ± 1.3 | 0.79 ± 0.15 | 0.28 |
Left atrium area, cm | 14.95 ± 4.37 | 15.56 ± 4.77 | 14.15 ± 3.71 | 0.17 |
Left atrium dimeter, cm | 3.28 ± 0.58 | 3.41 ± 0.59 | 3.13 ± 0.56 | 0.04 |
LA volume, cm2 | 37.59 ± 16.35 | 39.4 ± 19.51 | 35.07 ± 10.4 | 0.26 |
EDV, mL | 87.19 ± 29.17 | 91.81 ± 36.45 | 81.28 ± 14.04 | 0.08 |
ESV, mL | 41.87 ± 23.09 | 45.25 ± 28.78 | 37.69 ± 12.28 | 0.13 |
TRG max, mmHg | 22.91 ± 8.15 | 24 ± 9.05 | 21.34 ± 6.46 | 0.14 |
PAP, mmHg | 27.16 ± 8.21 | 28.7 ± 9.04 | 25.38 ± 6.86 | 0.09 |
IVC, cm | 1.50 ± 0.28 | 1.47 ± 0.28 | 1.53 ± 0.29 | 0.32 |
TAPSE | 21.33 ± 3.54 | 20.71 ± 3.81 | 22.24 ± 2.94 | 0.04* |
RVSP | 26.95 ± 7.07 | 27 ± 6.82 | 26.88 ± 7.56 | 0.95 |
SPAP | 26.72 ± 7.53 | 27.07 ± 8.19 | 26.19 ± 6.53 | 0.58 |
First follow GLS | − 0.36 ± 1.87 | -0.49 ± 2.44 | -0.19 ± 0.02 | 0.44 |